catalyst

A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative — primary completion

as of 2026-07-01
at a glance
2010-09 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative — primary completion
Type
Trial Readout
Date
2010-09
Date type
ACTUAL
Phase
Phase 2
This event happened.